The emerging role of pre-messenger RNA splicing in stress responses: Sending alternative messages and silent messengers

RNA Biology

Volumn 8, Issue 5, 2011, Pages

  Dutertre, Martin ^a,b,c   Sanchez, Gabriel ^f   Barbier, Jérôme ^g   Corcos, Laurent ^d,e   Auboeuf, Didier ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSERM   (France)

^e FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Apoptosis; DNA damage; Genotoxic stress; NMD; p53 MDM2 loop; Splicing

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; CAMPTOTHECIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; ISOPROTEIN; MESSENGER RNA; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; PROTEIN MDM2; PROTEIN P53; PROTEOME; TRANSCRIPTOME; UBIQUITIN PROTEIN LIGASE;

ALTERNATIVE RNA SPLICING; APOPTOSIS; CELLULAR DISTRIBUTION; EXON; GENE EXPRESSION; GENOTOXICITY; HUMAN; NONHUMAN; PROTEIN PROCESSING; REVIEW; STRESS; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION; X RAY;

EID: 80052801997     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.8.5.16016     Document Type: Review

References (71)

1. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10:741-54.
2. Dutertre M, Vagner S, Auboeuf D. Alternative splicing and breast cancer. RNA Biol 2010; 7:403-11.
3. Reinhardt HC, Cannell IG, Morandell S, Yaffe MB. Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response? Cell Cycle 2011; 10:23-7.
4. Amir-Ahmady B, Salati LM. Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status. J Biol Chem 2001; 276:10514-23.
5. Stamm S. Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum Mol Genet 2002; 11:2409-16. (Pubitemid 35174704)
6. Tacconelli A, Farina AR, Cappabianca L, Gulino A, Mackay AR. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma. Future Oncol 2005; 1:689-98.
7. Anderson CJ, Hoare SF, Ashcroft M, Bilsland AE, Keith WN. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 2006; 25:61-9. (Pubitemid 43050004)
8. Disher K, Skandalis A. Evidence of the modulation of mRNA splicing fidelity in humans by oxidative stress and p53. Genome 2007; 50:946-53. (Pubitemid 350158295)
9. Biamonti G, Caceres JF. Cellular stress and RNA splicing. Trends Biochem Sci 2009; 34:146-53.
10. Hang X, Li P, Li Z, Qu W, Yu Y, Li H, et al. Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array. BMC Genomics 2009; 10:126.
11. Takeo K, Kawai T, Nishida K, Masuda K, Teshima-Kondo S, Tanahashi T, et al. Oxidative stressinduced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells. Am J Physiol Cell Physiol 2009; 297:330-8.
12. Pleiss JA, Whitworth GB, Bergkessel M, Guthrie C. Rapid, transcript-specific changes in splicing in response to environmental stress. Mol Cell 2007; 27:928-37. (Pubitemid 47489768)
13. Shin C, Manley JL. Cell signalling and the control of pre-mRNA splicing. Nat Rev Mol Cell Biol 2004; 5:727-38. (Pubitemid 39208182)
14. Blaustein M, Pelisch F, Srebrow A. Signals, pathways and splicing regulation. Int J Biochem Cell Biol 2007; 39:2031-48. (Pubitemid 47376826)
15. Sumanasekera C, Watt DS, Stamm S. Substances that can change alternative splice-site selection. Biochem Soc Trans 2008; 36:483-90. (Pubitemid 351839360)
16. Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou JF, et al. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 1996; 381:80-2. (Pubitemid 26130007)
17. Pilch B, Allemand E, Facompre M, Bailly C, Riou JF, Soret J, et al. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly and splicing by the antitumor drug NB-506. Cancer Res 2001; 61:6876-84. (Pubitemid 32896513)
18. Filippov V, Filippova M, Duerksen-Hughes PJ. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes. Cancer Res 2007; 67:7621-30. (Pubitemid 47281354)
19. Busa R, Geremia R, Sette C. Genotoxic stress causes the accumulation of the splicing regulator Sam68 in nuclear foci of transcriptionally active chromatin. Nucleic Acids Res 2010; 38:3005-18.
20. Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, et al. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ 2008; 15:1815-23.
21. Munoz MJ, Perez Santangelo MS, Paronetto MP, de la Mata M, Pelisch F, Boireau S, et al. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 2009; 137:708-20.
22. Edmond V, Moysan E, Khochbin S, Matthias P, Brambilla C, Brambilla E, et al. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J 2011; 30:510-23.
23. Shkreta L, Michelle L, Toutant J, Tremblay ML, Chabot B. The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem 2010; 286:331-40.
24. Solier S, Lansiaux A, Logette E, Wu J, Soret J, Tazi J, et al. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol Cancer Res 2004; 2:53-61. (Pubitemid 38167108)
25. Solier S, Logette E, Desoche L, Solary E, Corcos L. Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA. Cell Death Differ 2005; 12:687-9. (Pubitemid 40767173)
26. Filippov V, Schmidt EL, Filippova M, Duerksen-Hughes PJ. Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. Gene 2008; 420:34-41.
27. Spriggs KA, Bushell M, Willis AE. Translational regulation of gene expression during conditions of cell stress. Mol Cell 2010; 40:228-37.
28. Barbier J, Dutertre M, Bittencourt D, Sanchez G, Gratadou L, de la Grange P, et al. Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways. Mol Cell Biol 2007; 27:7315-33. (Pubitemid 47549764)
29. Ip JY, Schmidt D, Pan Q, Ramani AK, Fraser AG, Odom DT, et al. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res 2011; 21:390-401.
30. Gardner LB. Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol Cancer Res 2010; 8:295-308.
31. Sayani S, Janis M, Lee CY, Toesca I, Chanfreau GF. Widespread impact of nonsense-mediated mRNA decay on the yeast intronome. Mol Cell 2008; 31:360-70.
32. Kleiman FE, Manley JL. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell 2001; 104:743-53. (Pubitemid 32241024)
33. Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993; 7:1126-32. (Pubitemid 23207405)
34. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9. (Pubitemid 27220766)
35. Chandler DS, Singh RK, Caldwell LC, Bitler JL, Lozano G. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res 2006; 66:9502-8. (Pubitemid 44623648)
36. Dias CS, Liu Y, Yau A, Westrick L, Evans SC. Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability. Cancer Res 2006; 66:9467-73. (Pubitemid 44623644)
37. Dutertre M, Sanchez G, De Cian MC, Barbier J, Dardenne E, Gratadou L, et al. Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 2010; 17:1358-66.
38. Stommel JM, Wahl GM. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation. Cell Cycle 2005; 4:411-7. (Pubitemid 41359726)
39. Savio MG, Rotondo G, Maglie S, Rossetti G, Bender JR, Pardi R. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene 2008; 27:2401-11. (Pubitemid 351521098)
40. Moyret-Lalle C, Duriez C, Van Kerckhove J, Gilbert C, Wang Q, Puisieux A. p53 induction prevents accumulation of aberrant transcripts in cancer cells. Cancer Res 2001; 61:486-8. (Pubitemid 32128603)
41. Li L, Liao J, Ruland J, Mak TW, Cohen SN. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci USA 2001; 98:1619-24. (Pubitemid 32165548)
42. Katzenberger RJ, Marengo MS, Wassarman DA. ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage. Mol Cell Biol 2006; 26:9256-67. (Pubitemid 44904421)
43. Solier S, Barb J, Zeeberg BR, Varma S, Ryan MC, Kohn KW, et al. Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. Cancer Res 2010; 70:8055-65.
44. Moore MJ, Wang Q, Kennedy CJ, Silver PA. An alternative splicing network links cell cycle control to apoptosis. Cell 2010; 142:625-36.
45. Cammas A, Lewis SM, Vagner S, Holcik M. Post-transcriptional control of gene expression through subcellular relocalization of mRNA binding proteins. Biochem Pharmacol 2008; 76:1395-403.
46. Anderson P, Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem Sci 2008; 33:141-50.
47. van der Houven van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Caceres JF. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J Cell Biol 2000; 149:307-16. (Pubitemid 30227149)
48. Shomron N, Alberstein M, Reznik M, Ast G. Stress alters the subcellular distribution of hSlu7 and thus modulates alternative splicing. J Cell Sci 2005; 118:1151-9. (Pubitemid 40528686)
49. Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A, et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 2008; 322:1511-6.
50. Gaudreault I, Guay D, Lebel M. YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucleic Acids Res 2004; 32:316-27. (Pubitemid 38228631)
51. Mirkin N, Fonseca D, Mohammed S, Cevher MA, Manley JL, Kleiman FE. The 3′ processing factor CstF functions in the DNA repair response. Nucleic Acids Res 2008; 36:1792-804. (Pubitemid 351494226)
52. Shin C, Feng Y, Manley JL. Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature 2004; 427:553-8. (Pubitemid 38209114)
53. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6. (Pubitemid 46877472)
54. Shultz JC, Goehe RW, Wijesinghe DS, Murudkar C, Hawkins AJ, Shay JW, et al. Alternative splicing of caspase 9 is modulated by the phosphoinositide-3- kinase/Akt pathway via phosphorylation of SRp30a. Cancer Res 2010; 70:9185-96.
55. Listerman I, Sapra AK, Neugebauer KM. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat Struct Mol Biol 2006; 13:815-22. (Pubitemid 44338776)
56. Bittencourt D, Dutertre M, Sanchez G, Barbier J, Gratadou L, Auboeuf D. Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes. Mol Cell Biol 2008; 28:5811-24.
57. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell 2011; 144:16-26.
58. Zorio DA, Bentley DL. The link between mRNA processing and transcription: communication works both ways. Exp Cell Res 2004; 296:91-7. (Pubitemid 38543218)
59. Sordet O, Larochelle S, Nicolas E, Stevens EV, Zhang C, Shokat KM, et al. Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I. J Mol Biol 2008; 381:540-9.
60. Ljungman M, O'Hagan HM, Paulsen MT. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation. Oncogene 2001; 20:5964-71. (Pubitemid 32955038)
61. Mellon I. Transcription-coupled repair: a complex affair. Mutat Res 2005; 577:155-61. (Pubitemid 41225495)
62. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6:789-802. (Pubitemid 44450467)
63. Czubaty A, Girstun A, Kowalska-Loth B, Trzcinska AM, Purta E, Winczura A, et al. Proteomic analysis of complexes formed by human topoisomerase I. Biochim Biophys Acta 2005; 1749:133-41.
64. Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene 1998; 17:603-10. (Pubitemid 28401029)
65. Chansky HA, Hu M, Hickstein DD, Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Research 2001; 61:3586-90. (Pubitemid 32694966)
66. Stickeler E, Fraser SD, Honig A, Chen AL, Berget SM, Cooper TA. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 2001; 20:3821-30. (Pubitemid 32691793)
67. Hartmuth K, Urlaub H, Vornlocher HP, Will CL, Gentzel M, Wilm M, et al. Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method. Proc Natl Acad Sci USA 2002; 99:16719-24. (Pubitemid 36034039)
68. Fan L, Lagisetti C, Edwards CC, Webb TR, Potter PM. Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing. ACS Chem Biol 2011; PMID: 21344922.
69. Pagani F, Stuani C, Zuccato E, Kornblihtt AR, Baralle FE. Promoter architecture modulates CFTR exon 9 skipping. J Biol Chem 2003; 278:1511-7. (Pubitemid 36801378)
70. Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic 2006; 5:8-14. (Pubitemid 46402988)
71. Shibahara K, Uchiumi T, Fukuda T, Kura S, Tominaga Y, Maehara Y, et al. Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C. Cancer Sci 2004; 95:348-53. (Pubitemid 38519476)